With Wegovy in its portfolio, Novo Nordisk is a very good bet to continue being a winner. As it's currently considered something of an underdog, with its stock priced accordingly, it's also trading at ...

Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...

Instead, McDowell snagged an invite, through his friend Donald Trump Jr., to a falconry trip Kennedy hosted. On a sunny day ...

BT: How does Novo Nordisk view competition in the obesity treatment space? VS: Obesity is a complex chronic disease affecting millions globally. Tackling it requires a collective effort — no ...

It has been a tough period for Novo Nordisk shareholders. In the summer of 2024 ... particularly involving the U.S., remain a background concern. “Japan is a high-priority market for Denmark, and ...

According to White, no such arguments took place. “We never really even fought. He says we feuded. I don’t think I ever had a fight with him — except for maybe some emails,” White said ...

SAO PAULO (Reuters) - Novo Nordisk, the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil to boost production, it said on Monday. The ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

LONDON/COPENHAGEN (Reuters) -Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, nearly doubled annual income and investment returns to a record 8 billion euros ($8.66 ...